Short answer
Sabra Health Care REIT, Inc. (SBRA) filed an 8-K current report with the SEC on August 3, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Sabra reported second-quarter 2026 results for the three months ended June 30, 2026.
Sabra Health Care REIT, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Sabra reported second-quarter 2026 results for the three months ended June 30, 2026
- Press release furnished as Exhibit 99.1, with non-GAAP reconciliations in Exhibit 99.3
- Investors should review the exhibits for operating performance and non-GAAP metrics valuing REIT earnings
Item 7.01 · Regulation FD Disclosure
- Supplemental information package furnished as Exhibit 99.2 and available on Sabra’s investor website
- Exhibit 99.4 presentation materials intended for investor presentations
- Materials under Items 2.02 and 7.01 excluded from Exchange Act Section 18 filing liability
- Exhibits 99.1–99.4 not incorporated into other filings unless expressly referenced
Item EX-99.1 · Exhibit EX-99.1
- Q2 normalized FFO $0.38 and normalized AFFO $0.40 per share, supporting the $0.30 quarterly dividend
- GAAP net loss $(0.10) per share, driven by a $102.4M provision for loan losses and other reserves
- $274.1M invested during Q2 at an 8.1% initial cash yield, with $223.0M of additional acquisitions completed after quarter-end
- Same-property managed senior housing cash NOI increased 13.7% year over year, signaling strong operating momentum
- Liquidity approximately $1.3B and net debt to adjusted EBITDA 4.61x, preserving capacity for further acquisitions
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Sabra Health Care REIT, Inc. 8-K filings
Get the next SBRA 8-K as it lands
Follow SBRA for push alerts, or ask the research agent what this filing means.